Molbio Diagnostics Ltd approves unaudited Q2 and H1 FY27 results for the period ended September 30, 2026
- Auditor issued an unmodified limited-review opinion; financial figures were not included in the announcement.
- Board noted President and Chief Medical Officer Dr. Kuldeep Singh Sachdeva’s resignation, effective January 21, 2027.
- Approved Rakesh Hulihalli & Associates as secretarial auditor for FY2026-27 to FY2030-31, subject to shareholder approval, and approved the IPO-proceeds monitoring agency report and a postal ballot notice.